Where Is the Trace? Molecular Imaging of Vulnerable Atherosclerotic Plaques

 

 Buy Article Permissions and Reprints

ABSTRACT

Serious cardiovascular events frequently arise from rupture of vulnerable atherosclerotic plaques. Not infrequently, these plaques are clinically silent and suddenly cause acute complications such as myocardial infarction, which in a high percentage are fatal. Thus, identifying individual patients with vulnerable plaques at high risk for plaque rupture is a central challenge in clinical medicine. This review highlights noninvasive scintigraphic techniques, which use radiolabeled molecules to detect functional aspects in atherosclerotic plaques by visualizing their biological activity. One major principle is the molecular imaging of inflammation with radionuclide tracers, including detection of metabolic activity, chemotaxis, cell recruitment, and lipoprotein enrichment. Additional studies focus on visualization of apoptosis, angiogenesis, or proteolysis. A central feature of plaque vulnerability is its thrombogenicity. Therefore, detection of thrombogenic plaques is another promising principle of molecular imaging. If a reliable protocol to image vulnerable plaques, which are prone to rupture, can be established and introduced into clinical practice, the required measures such as atheroprotective medication or revascularization could be undertaken to prevent serious cardiovascular events.

REFERENCES

• 1 Myerburg R J, Interian Jr A, Mitrani R M, Kessler K M, Castellanos A. Frequency of sudden cardiac death and profiles of risk.  Am J Cardiol. 1997;  80 10F-19F
  CrossrefPubMedGoogle Scholar
• 2 Nissen S E, Yock P. Intravascular ultrasound: novel pathophysiological insights and current clinical applications.  Circulation. 2001;  103 604-616
  PubMedGoogle Scholar
• 3 Schroeder S, Kopp A F, Baumbach A et al.. Noninvasive detection and evaluation of atherosclerotic coronary plaques with multislice computed tomography.  J Am Coll Cardiol. 2001;  37 1430-1435
  CrossrefPubMedGoogle Scholar
• 4 Schmermund A, Erbel R. Unstable coronary plaque and its relation to coronary calcium.  Circulation. 2001;  104 1682-1687
  PubMedGoogle Scholar
• 5 Naghavi M, Libby P, Falk E et al.. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: part II.  Circulation. 2003;  108 1772-1778
  CrossrefPubMedGoogle Scholar
• 6 Ross R. Atherosclerosis-an inflammatory disease.  N Engl J Med. 1999;  340 115-126
  CrossrefPubMedGoogle Scholar
• 7 Libby P. Inflammation in atherosclerosis.  Nature. 2002;  420 868-874
  CrossrefPubMedGoogle Scholar
• 8 Ogawa M, Ishino S, Mukai T et al.. (18)F-FDG accumulation in atherosclerotic plaques: immunohistochemical and PET imaging study.  J Nucl Med. 2004;  45 1245-1250
  PubMedGoogle Scholar
• 9 Rudd J H, Warburton E A, Fryer T D et al.. Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography.  Circulation. 2002;  105 2708-2711
  CrossrefPubMedGoogle Scholar
• 10 Gawaz M, Neumann F J, Dickfeld T et al.. Activated platelets induce monocyte chemotactic protein-1 secretion and surface expression of intercellular adhesion molecule-1 on endothelial cells.  Circulation. 1998;  98 1164-1171
  PubMedGoogle Scholar
• 11 Ohtsuki K, Hayase M, Akashi K, Kopiwoda S, Strauss H W. Detection of monocyte chemoattractant protein-1 receptor expression in experimental atherosclerotic lesions: an autoradiographic study.  Circulation. 2001;  104 203-208
  PubMedGoogle Scholar
• 12 Virgolini I, Muller C, Fitscha P, Chiba P, Sinzinger H. Radiolabelling autologous monocytes with 111-indium-oxine for reinjection in patients with atherosclerosis.  Prog Clin Biol Res. 1990;  355 271-280
  PubMedGoogle Scholar
• 13 Haubner R, Wester H J, Burkhart F et al.. Glycosylated RGD-containing peptides: tracer for tumor targeting and angiogenesis imaging with improved biokinetics.  J Nucl Med. 2001;  42 326-336
  PubMedGoogle Scholar
• 14 Janssen M L, Oyen W J, Dijkgraaf I et al.. Tumor targeting with radiolabeled alpha(v)beta(3) integrin binding peptides in a nude mouse model.  Cancer Res. 2002;  62 6146-6151
  PubMedGoogle Scholar
• 15 Matter C M, Schuler P K, Alessi P et al.. Molecular imaging of atherosclerotic plaques using a human antibody against the extra-domain B of fibronectin.  Circ Res. 2004;  95 1225-1233
  CrossrefPubMedGoogle Scholar
• 16 Virgolini I, Rauscha F, Lupattelli G et al.. Autologous low-density lipoprotein labelling allows characterization of human atherosclerotic lesions in vivo as to presence of foam cells and endothelial coverage.  Eur J Nucl Med. 1991;  18 948-951
  PubMedGoogle Scholar
• 17 Virgolini I, Angelberger P, O'Grady J, Sinzinger H. Low density lipoprotein labelling characterizes experimentally induced atherosclerotic lesions in rabbits in vivo as to presence of foam cells and endothelial coverage.  Eur J Nucl Med. 1991;  18 944-947
  PubMedGoogle Scholar
• 18 Tsimikas S, Palinski W, Witztum J L. Circulating autoantibodies to oxidized LDL correlate with arterial accumulation and depletion of oxidized LDL in LDL receptor-deficient mice.  Arterioscler Thromb Vasc Biol. 2001;  21 95-100
  PubMedGoogle Scholar
• 19 Tsimikas S. Noninvasive imaging of oxidized low-density lipoprotein in atherosclerotic plaques with tagged oxidation-specific antibodies.  Am J Cardiol. 2002;  90 22L-27L
  CrossrefPubMedGoogle Scholar
• 20 Tsimikas S, Shortal B P, Witztum J L, Palinski W. In vivo uptake of radiolabeled MDA2, an oxidation-specific monoclonal antibody, provides an accurate measure of atherosclerotic lesions rich in oxidized LDL and is highly sensitive to their regression.  Arterioscler Thromb Vasc Biol. 2000;  20 689-697
  PubMedGoogle Scholar
• 21 Iuliano L, Signore A, Vallabajosula S et al.. Preparation and biodistribution of 99m technetium labelled oxidized LDL in man.  Atherosclerosis. 1996;  126 131-141
  CrossrefPubMedGoogle Scholar
• 22 Geng Y J, Libby P. Evidence for apoptosis in advanced human atheroma. Colocalization with interleukin-1 beta-converting enzyme.  Am J Pathol. 1995;  147 251-266
  PubMedGoogle Scholar
• 23 Thomas W A, Scott R F, Florentin R A, Reiner J M, Lee K T. Population dynamics of arterial cells during atherogenesis. XI. Slowdown in multiplication and death rates of lesion smooth muscle cells in swine during the period 105-165 days after balloon endothelial cell denudation followed by a hyperlipidemic diet.  Exp Mol Pathol. 1981;  35 153-162
  CrossrefPubMedGoogle Scholar
• 24 Thomas W A, Kim D N, Lee K T, Reiner J M, Schmee J. Population dynamics of arterial cells during atherogenesis. XIII. Mitogenic and cytotoxic effects of a hyperlipidemic (HL) diet on cells in advanced lesions in the abdominal aortas of swine fed an HL diet for 270-345 days.  Exp Mol Pathol. 1983;  39 257-270
  CrossrefPubMedGoogle Scholar
• 25 Johnson L L, Schofield L, Donahay T, Narula N, Narula J. 99mTc-annexin V imaging for in vivo detection of atherosclerotic lesions in porcine coronary arteries.  J Nucl Med. 2005;  46 1186-1193
  PubMedGoogle Scholar
• 26 Narula J, Acio E R, Narula N et al.. Annexin-V imaging for noninvasive detection of cardiac allograft rejection.  Nat Med. 2001;  7 1347-1352
  PubMedGoogle Scholar
• 27 Hofstra L, Liem I H, Dumont E A et al.. Visualisation of cell death in vivo in patients with acute myocardial infarction.  Lancet. 2000;  356 209-212
  CrossrefPubMedGoogle Scholar
• 28 Kolodgie F D, Petrov A, Virmani R et al.. Targeting of apoptotic macrophages and experimental atheroma with radiolabeled annexin V: a technique with potential for noninvasive imaging of vulnerable plaque.  Circulation. 2003;  108 3134-3139
  CrossrefPubMedGoogle Scholar
• 29 Schafers M, Riemann B, Kopka K et al.. Scintigraphic imaging of matrix metalloproteinase activity in the arterial wall in vivo.  Circulation. 2004;  109 2554-2559
  CrossrefPubMedGoogle Scholar
• 30 Langer H, Gawaz M. Molecular imaging of vulnerable atherosclerotic plaques.  Future Cardiology. 2006;  2 113-122
  CrossrefPubMedGoogle Scholar
• 31 Minar E, Ehringer H, Dudczak R et al.. Indium-111-labeled platelet scintigraphy in carotid atherosclerosis.  Stroke. 1989;  20 27-33
  PubMedGoogle Scholar
• 32 Moriwaki H, Matsumoto M, Handa N et al.. Functional and anatomic evaluation of carotid atherothrombosis. A combined study of indium 111 platelet scintigraphy and B-mode ultrasonography.  Arterioscler Thromb Vasc Biol. 1995;  15 2234-2240
  PubMedGoogle Scholar
• 33 Smyth J V, Dodd P D, Walker M G. Indium-111 platelet scintigraphy in vascular disease.  Br J Surg. 1995;  82 588-595
  CrossrefPubMedGoogle Scholar
• 34 Vallabhajosula S. Technetium-99m-P748, platelet specific techtide for imaging arterial thrombus: preclinical studies in a canine model of intra-arterial thrombus.  J Nucl Med. 2005;  7 152(abst)
  PubMedGoogle Scholar
• 35 Cerqueira M D, Stratton J R, Vracko R, Schaible T F, Ritchie J L. Noninvasive arterial thrombus imaging with 99mTc monoclonal antifibrin antibody.  Circulation. 1992;  85 298-304
  PubMedGoogle Scholar
• 36 Greco C, Di Loreto M, Ciavolella M et al.. Immunodetection of human atherosclerotic plaque with 125I-labeled monoclonal antifibrin antibodies.  Atherosclerosis. 1993;  100 133-139
  CrossrefPubMedGoogle Scholar
• 37 Clemetson K J, Clemetson J M. Platelet collagen receptors.  Thromb Haemost. 2001;  86 189-197
  Article in Thieme ConnectPubMedGoogle Scholar
• 38 Nieswandt B, Watson S P. Platelet-collagen interaction: is GPVI the central receptor?.  Blood. 2003;  102 449-461
  CrossrefPubMedGoogle Scholar
• 39 Massberg S, Konrad I, Bultmann A et al.. Soluble glycoprotein VI dimer inhibits platelet adhesion and aggregation to the injured vessel wall in vivo.  FASEB J. 2004;  18 397-399
  PubMedGoogle Scholar
• 40 Moers A, Nieswandt B, Massberg S et al.. G13 is an essential mediator of platelet activation in hemostasis and thrombosis.  Nat Med. 2003;  9 1418-1422
  PubMedGoogle Scholar
• 41 Gawaz M, Konrad I, Hauser A I et al.. Non-invasive imaging of glycoprotein VI binding to injured arterial lesions.  Thromb Haemost. 2005;  93 910-913
  PubMedGoogle Scholar
• 42 Fuster V, Badimon L, Badimon J J, Chesebro J H. The pathogenesis of coronary artery disease and the acute coronary syndromes (1).  N Engl J Med. 1992;  326 242-250
  CrossrefPubMedGoogle Scholar
• 43 Farb A, Burke A P, Tang A L et al.. Coronary plaque erosion without rupture into a lipid core. A frequent cause of coronary thrombosis in sudden coronary death.  Circulation. 1996;  93 1354-1363
  CrossrefPubMedGoogle Scholar

Harald LangerM.D. 

Medizinische Klinik III, Universitätsklinikum Tübingen

Otfried-Müller Str. 10, 72076 Tübingen, Germany

Email: harald.langer@med.uni-tuebingen.de